Stockscreener 앱 받기
14.08
2.18%
0.30
시간 외 거래:
14.08
전일 마감가:
$13.78
열려 있는:
$13.56
하루 거래량:
316.19K
Relative Volume:
0.98
시가총액:
$694.37M
수익:
-
순이익/손실:
$-91.76M
주가수익비율:
-2.5815
EPS:
-5.4541
순현금흐름:
$-94.89M
1주 성능:
+1.59%
1개월 성능:
-3.23%
6개월 성능:
+89.76%
1년 성능:
+0.00%
1일 변동 폭
$13.13
$14.28
1주일 범위
$13.13
$15.15
52주 변동 폭
$6.565
$17.71
Jade Biosciences Inc Stock (JBIO) Company Profile
명칭
Jade Biosciences Inc
전화
(781) 312-3013
주소
221 CRESCENT ST., WALTHAM
Compare JBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
14.08 | 679.58M | 0 | -91.76M | -94.89M | -5.4541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | H.C. Wainwright | Buy |
| 2025-10-09 | 개시 | BTIG Research | Buy |
| 2025-07-14 | 개시 | Jefferies | Buy |
| 2025-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2025-05-07 | 개시 | Wedbush | Outperform |
| 2025-05-05 | 개시 | Stifel | Buy |
| 2025-05-02 | 개시 | TD Cowen | Buy |
| 2024-06-18 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-06-18 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-06-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-03-25 | 재개 | Jefferies | Buy |
| 2023-12-08 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2022-12-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-08-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-02-11 | 개시 | BTIG Research | Buy |
| 2021-07-26 | 개시 | Cowen | Outperform |
| 2021-07-26 | 개시 | Evercore ISI | Outperform |
| 2021-07-26 | 개시 | Jefferies | Buy |
| 2021-07-26 | 개시 | Wedbush | Outperform |
모두보기
Jade Biosciences Inc 주식(JBIO)의 최신 뉴스
Jade Biosciences, Inc.(NasdaqCM: JBIO) added to S&P Biotechnology Select Industry Index - marketscreener.com
Portfolio Recap: Is Jade Biosciences Inc forming a bullish divergenceWeekly Trading Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Shares Gap Up After Analyst Upgrade - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $39.00 at BTIG Research - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
Jade Biosciences (NASDAQ:JBIO) Cut to Strong Sell at Zacks Research - Defense World
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell - MarketBeat
Guggenheim Forecasts Strong Price Appreciation for Jade Biosciences (NASDAQ:JBIO) Stock - MarketBeat
Guggenheim raises Jade Biosciences stock price target on pipeline progress By Investing.com - Investing.com Canada
William Blair Upgrades Jade Biosciences (NASDAQ:JBIO) to Strong-Buy - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Jade Biosciences (NASDAQ:JBIO) Raised to "Strong-Buy" at William Blair - MarketBeat
TD Cowen reiterates Jade Biosciences stock rating on APRIL data By Investing.com - Investing.com Canada
William Blair initiates Jade Biosciences stock coverage with Outperform rating - Investing.com UK
Trading Recap: Is Jade Biosciences Inc a speculative investment2026 Breakouts & Accurate Buy Signal Alerts - baoquankhu1.vn
Wedbush Reaffirms Outperform Rating for Jade Biosciences (NASDAQ:JBIO) - MarketBeat
William Blair initiates Jade Biosciences stock coverage with Outperform rating By Investing.com - Investing.com India
Signal Recap: Is Jade Biosciences Inc a speculative investment2026 Historical Comparison & Weekly Stock Performance Updates - baoquankhu1.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Raised to “Strong-Buy” at Lifesci Capital - Defense World
Jade Biosciences (NASDAQ:JBIO) Upgraded by Lifesci Capital to "Strong-Buy" Rating - MarketBeat
Jade 10-K: $127.4M net loss, cash and investments $336.2M - TradingView
BTIG reiterates Buy on Jade Biosciences stock, $28 target maintained By Investing.com - Investing.com Canada
Stifel raises Jade Biosciences price target on IgAN market outlook By Investing.com - Investing.com South Africa
Stifel raises Jade Biosciences price target on IgAN market outlook - Investing.com
Jade Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Jade Biosciences reports fourth quarter and full year 2025 financial results and provides corporate update - marketscreener.com
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Jade Biosciences Stock Quote, Share Price, News and Analysis - Longbridge
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears - Defense World
JBIO Should I Buy - Intellectia AI
JBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Context Therapeutics (CNTX) and MBX Biosciences, Inc. (MBX) - The Globe and Mail
Oppenheimer 36th Healthcare Life Sciences Conference: Spotlight On LGND, PHAR, CRBP, Among Others - RTTNews
Chipmakers Recap: Is Jade Biosciences Inc a stock for growth or value investors2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Can Jade Biosciences Inc. expand its profit marginsWeekly Profit Recap & Safe Entry Zone Tips - mfd.ru
Jade Biosciences (JBIO) grants RSUs and 247,500-share option to officer - Stock Titan
Weekly Earnings: Is Jade Biosciences Inc a speculative investmentJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpHere's Why - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat
Aug Sentiment: Is Jade Biosciences Inc a speculative investment2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Up 8.1%What's Next? - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3%Here's What Happened - MarketBeat
Economics Weekly : There's Something About Kevin - William Blair
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz
Jade Biosciences Inc (JBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):